{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>internal_id</th>\n",
       "      <th>abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Phase 2 study of DRD2 antagonist/ClpP agonist ONC201 in neuroendocrine tumors.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>First-in-human biomarker-driven phase I trial of the potent and selective glutaminase-1 (GLS1) inhibitor IACS-6274 (IPN60090) in patients (pts) with molecularly selected advanced solid tumors.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>MyPathway HER2 basket study: Pertuzumab (P) + trastuzumab (H) treatment of a large, tissue-agnostic cohort of patients with HER2-positive advanced solid tumors.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   internal_id  \\\n",
       "0            1   \n",
       "1            2   \n",
       "2            3   \n",
       "3            4   \n",
       "4            5   \n",
       "\n",
       "                                                                                                                                                                                           abstract  \n",
       "0                                                                                                                    Phase 2 study of DRD2 antagonist/ClpP agonist ONC201 in neuroendocrine tumors.  \n",
       "1  First-in-human biomarker-driven phase I trial of the potent and selective glutaminase-1 (GLS1) inhibitor IACS-6274 (IPN60090) in patients (pts) with molecularly selected advanced solid tumors.  \n",
       "2                                                                                      Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors.  \n",
       "3                                  MyPathway HER2 basket study: Pertuzumab (P) + trastuzumab (H) treatment of a large, tissue-agnostic cohort of patients with HER2-positive advanced solid tumors.  \n",
       "4                                                                                        A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors.  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#importing file containig Abstract text\n",
    "abs=pd.read_csv('Abstracts.csv')\n",
    "pd.set_option('display.max_colwidth', None)\n",
    "abs.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>term</th>\n",
       "      <th>type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>H.R.-50</td>\n",
       "      <td>Drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Rectacort - HC</td>\n",
       "      <td>Drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Neo-Cobefrin</td>\n",
       "      <td>Drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Duo-Medihaler</td>\n",
       "      <td>Drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Pseudo-12</td>\n",
       "      <td>Drug</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "             term  type\n",
       "0         H.R.-50  Drug\n",
       "1  Rectacort - HC  Drug\n",
       "2    Neo-Cobefrin  Drug\n",
       "3   Duo-Medihaler  Drug\n",
       "4       Pseudo-12  Drug"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Importing file containig drug and disease information\n",
    "drug=pd.read_csv('Drugs.csv')\n",
    "drug.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Converting drug dataframe to csv\n",
    "drug_dict=dict(zip(drug.term, drug.type))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "df=abs.copy()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Function to extract disease name from the text\n",
    "def extract_disease(s):\n",
    "    l=[]\n",
    "    for i in drug_dict.keys():\n",
    "\n",
    "        if s.find(i)==-1:\n",
    "            continue\n",
    "        else:\n",
    "            if drug_dict[i]=='Disease':\n",
    "                l.append(i)\n",
    "            else:\n",
    "                return ''\n",
    "    return \";;\".join(l)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Function to extract drug name from the text\n",
    "def extract_drug(s):\n",
    "    l=[]\n",
    "    for i in drug_dict.keys():\n",
    "        \n",
    "        if s.find(i)==-1:\n",
    "            continue\n",
    "        else:\n",
    "            if drug_dict[i]=='Drug':\n",
    "                l.append(i)\n",
    "            else:\n",
    "                return ''\n",
    "    return \";;\".join(l)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Extracting disease and drug name and filling it in respective columns\n",
    "df['disease']=df['abstract'].apply(extract_disease)\n",
    "df['drug']=df['abstract'].apply(extract_drug)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>internal_id</th>\n",
       "      <th>abstract</th>\n",
       "      <th>disease</th>\n",
       "      <th>drug</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Phase 2 study of DRD2 antagonist/ClpP agonist ONC201 in neuroendocrine tumors.</td>\n",
       "      <td>tumor;;endocrine tumors;;neuroendocrine tumors</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>First-in-human biomarker-driven phase I trial of the potent and selective glutaminase-1 (GLS1) inhibitor IACS-6274 (IPN60090) in patients (pts) with molecularly selected advanced solid tumors.</td>\n",
       "      <td>tumor;;solid tumors</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors.</td>\n",
       "      <td>tumor;;solid tumors</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>MyPathway HER2 basket study: Pertuzumab (P) + trastuzumab (H) treatment of a large, tissue-agnostic cohort of patients with HER2-positive advanced solid tumors.</td>\n",
       "      <td>tumor;;solid tumors</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors.</td>\n",
       "      <td>tumor;;solid tumors</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   internal_id  \\\n",
       "0            1   \n",
       "1            2   \n",
       "2            3   \n",
       "3            4   \n",
       "4            5   \n",
       "\n",
       "                                                                                                                                                                                           abstract  \\\n",
       "0                                                                                                                    Phase 2 study of DRD2 antagonist/ClpP agonist ONC201 in neuroendocrine tumors.   \n",
       "1  First-in-human biomarker-driven phase I trial of the potent and selective glutaminase-1 (GLS1) inhibitor IACS-6274 (IPN60090) in patients (pts) with molecularly selected advanced solid tumors.   \n",
       "2                                                                                      Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors.   \n",
       "3                                  MyPathway HER2 basket study: Pertuzumab (P) + trastuzumab (H) treatment of a large, tissue-agnostic cohort of patients with HER2-positive advanced solid tumors.   \n",
       "4                                                                                        A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors.   \n",
       "\n",
       "                                          disease drug  \n",
       "0  tumor;;endocrine tumors;;neuroendocrine tumors       \n",
       "1                             tumor;;solid tumors       \n",
       "2                             tumor;;solid tumors       \n",
       "3                             tumor;;solid tumors       \n",
       "4                             tumor;;solid tumors       "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#From the above output,we can see that some words are being repeated which are unnecessary\n",
    "#For this we need to perform some sort of cleaning to remove unnecesary words"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Function to avoid repeatation\n",
    "def clean(s):\n",
    "    l=s.split(';;')\n",
    "    l1=l.copy()\n",
    "    for i in l:\n",
    "        for j in l1:\n",
    "            try:\n",
    "                if i == j:continue\n",
    "                if i in j:\n",
    "                    l1.remove(i)\n",
    "                  \n",
    "            except Exception as e: return \";;\".join(l1) \n",
    "              \n",
    "    return \";;\".join(l1) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "df1=df.copy()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Cleaning of disease and drug column\n",
    "df1['disease']=df1['disease'].apply(clean)\n",
    "df1['drug']=df1['drug'].apply(clean)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>internal_id</th>\n",
       "      <th>abstract</th>\n",
       "      <th>disease</th>\n",
       "      <th>drug</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Phase 2 study of DRD2 antagonist/ClpP agonist ONC201 in neuroendocrine tumors.</td>\n",
       "      <td>neuroendocrine tumors</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>First-in-human biomarker-driven phase I trial of the potent and selective glutaminase-1 (GLS1) inhibitor IACS-6274 (IPN60090) in patients (pts) with molecularly selected advanced solid tumors.</td>\n",
       "      <td>solid tumors</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors.</td>\n",
       "      <td>solid tumors</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>MyPathway HER2 basket study: Pertuzumab (P) + trastuzumab (H) treatment of a large, tissue-agnostic cohort of patients with HER2-positive advanced solid tumors.</td>\n",
       "      <td>solid tumors</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors.</td>\n",
       "      <td>solid tumors</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5249</th>\n",
       "      <td>5325</td>\n",
       "      <td>Adult malignancy-associated hemophagocytic lymphohistiocytosis: Case series.</td>\n",
       "      <td>hemophagocytic lymphohistiocytosi</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5250</th>\n",
       "      <td>5326</td>\n",
       "      <td>Safety of same day HD-MTX with induction therapy for DLBCL with concurrent CNS disease or as prophylaxis for high risk of CNS relapse.</td>\n",
       "      <td>DLBCL</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5251</th>\n",
       "      <td>5327</td>\n",
       "      <td>A retrospective study of efficacy and safety of mechlorethamine, vindesine, liposomal doxorubicin, and prednisone (MODP) in relapsed/refractory classical Hodgkin lymphoma.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5252</th>\n",
       "      <td>5328</td>\n",
       "      <td>Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma treated with R-CHOP.</td>\n",
       "      <td>BCL</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5253</th>\n",
       "      <td>5329</td>\n",
       "      <td>Clinical characteristics and outcomes of adult lymphoma-associated hemophagocytic lymphohistiocytosis (HLH).</td>\n",
       "      <td>HLH;;hemophagocytic lymphohistiocytosi</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5254 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      internal_id  \\\n",
       "0               1   \n",
       "1               2   \n",
       "2               3   \n",
       "3               4   \n",
       "4               5   \n",
       "...           ...   \n",
       "5249         5325   \n",
       "5250         5326   \n",
       "5251         5327   \n",
       "5252         5328   \n",
       "5253         5329   \n",
       "\n",
       "                                                                                                                                                                                              abstract  \\\n",
       "0                                                                                                                       Phase 2 study of DRD2 antagonist/ClpP agonist ONC201 in neuroendocrine tumors.   \n",
       "1     First-in-human biomarker-driven phase I trial of the potent and selective glutaminase-1 (GLS1) inhibitor IACS-6274 (IPN60090) in patients (pts) with molecularly selected advanced solid tumors.   \n",
       "2                                                                                         Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors.   \n",
       "3                                     MyPathway HER2 basket study: Pertuzumab (P) + trastuzumab (H) treatment of a large, tissue-agnostic cohort of patients with HER2-positive advanced solid tumors.   \n",
       "4                                                                                           A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors.   \n",
       "...                                                                                                                                                                                                ...   \n",
       "5249                                                                                                                      Adult malignancy-associated hemophagocytic lymphohistiocytosis: Case series.   \n",
       "5250                                                            Safety of same day HD-MTX with induction therapy for DLBCL with concurrent CNS disease or as prophylaxis for high risk of CNS relapse.   \n",
       "5251                       A retrospective study of efficacy and safety of mechlorethamine, vindesine, liposomal doxorubicin, and prednisone (MODP) in relapsed/refractory classical Hodgkin lymphoma.   \n",
       "5252                                                                                      Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma treated with R-CHOP.   \n",
       "5253                                                                                      Clinical characteristics and outcomes of adult lymphoma-associated hemophagocytic lymphohistiocytosis (HLH).   \n",
       "\n",
       "                                     disease drug  \n",
       "0                      neuroendocrine tumors       \n",
       "1                               solid tumors       \n",
       "2                               solid tumors       \n",
       "3                               solid tumors       \n",
       "4                               solid tumors       \n",
       "...                                      ...  ...  \n",
       "5249       hemophagocytic lymphohistiocytosi       \n",
       "5250                                   DLBCL       \n",
       "5251                                               \n",
       "5252                                     BCL       \n",
       "5253  HLH;;hemophagocytic lymphohistiocytosi       \n",
       "\n",
       "[5254 rows x 4 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Final output\n",
    "df1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Converting the dataset to excel file\n",
    "df1.to_excel('Drug_Disease_detect.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
